Rovin Capital UT ADV Lowers Position in Agilent Technologies, Inc. (NYSE:A)

Rovin Capital UT ADV trimmed its position in shares of Agilent Technologies, Inc. (NYSE:A) by 20.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,021 shares of the medical research company’s stock after selling 1,028 shares during the quarter. Rovin Capital UT ADV’s holdings in Agilent Technologies were worth $540,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. Massachusetts Financial Services Co. MA increased its position in shares of Agilent Technologies by 3.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock valued at $2,314,784,000 after acquiring an additional 525,214 shares during the last quarter. State Street Corp raised its stake in shares of Agilent Technologies by 1.2% during the 3rd quarter. State Street Corp now owns 12,819,897 shares of the medical research company’s stock worth $1,903,498,000 after purchasing an additional 158,175 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Agilent Technologies by 0.4% in the 3rd quarter. Geode Capital Management LLC now owns 6,948,679 shares of the medical research company’s stock worth $1,028,241,000 after buying an additional 30,610 shares during the last quarter. Nordea Investment Management AB boosted its stake in Agilent Technologies by 2.6% in the fourth quarter. Nordea Investment Management AB now owns 3,198,715 shares of the medical research company’s stock valued at $431,603,000 after acquiring an additional 80,819 shares during the last quarter. Finally, Van ECK Associates Corp grew its position in shares of Agilent Technologies by 6.6% during the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock valued at $442,011,000 after acquiring an additional 183,716 shares during the period. Institutional investors own 87.42% of the company’s stock.

Agilent Technologies Trading Down 0.9 %

Shares of A stock opened at $142.19 on Thursday. Agilent Technologies, Inc. has a 52-week low of $124.16 and a 52-week high of $155.35. The business’s fifty day moving average is $136.07 and its 200 day moving average is $136.96. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.58 and a current ratio of 2.09. The company has a market capitalization of $40.61 billion, a PE ratio of 32.17, a price-to-earnings-growth ratio of 4.48 and a beta of 1.06.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. The firm had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The company’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter last year, the company posted $1.38 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.56 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.248 per share. The ex-dividend date is Tuesday, December 31st. This represents a $0.99 annualized dividend and a dividend yield of 0.70%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is 22.40%.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. JPMorgan Chase & Co. dropped their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 26th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Barclays cut their price target on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating for the company in a research note on Wednesday, November 27th. Bank of America lowered their price objective on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research note on Friday, December 13th. Finally, Wells Fargo & Company cut their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Agilent Technologies has a consensus rating of “Hold” and a consensus price target of $143.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.